Clinical Trial of Naoqingzhiming Tablets in Healthy Chinese Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A single-center, randomized, double-blind, placebo-controlled, dose escalation safety, tolerability, and pharmacokinetic phase I clinical study of Naoqingzhiming Tablets in Chinese healthy subjects.
Epistemonikos ID: dc9062901d16391340a3db70ca74a4a04196b59a
First added on: May 08, 2024